Find uplifting stories about heroes, innovations, and solutions
7567 results for "epilepsy treatment"
Researchers at Mayo Clinic have created a detailed map of a deep brain region that could help doctors precisely target therapies for people with drug-resistant epilepsy. The discovery shows that brain areas just 3 millimeters apart connect to completely different networks, providing a blueprint for more effective treatment.
Children with a devastating form of epilepsy may soon have new hope thanks to promising trial results from an experimental treatment. Praxis Precision Medicines announced their drug elsunersen successfully reduced seizures in early testing for SCN2A-related epilepsy.
Scientists in Jerusalem discovered a tiny peptide that not only reduces seizures but protects brain cells from long-term damage in treatment-resistant epilepsy. For the 40% of epilepsy patients who don't respond well to current medications, this breakthrough offers new hope.
A breakthrough treatment for seizure disorders exceeded expectations in its final clinical trial, bringing hope to millions who live with epilepsy. The drug reduced seizure frequency significantly and could reach patients by late 2026.
A breakthrough medication helped highly treatment-resistant epilepsy patients reduce their seizures by more than half in a major clinical trial. The once-daily pill works through an entirely new mechanism and could reach patients by next year.
A breakthrough treatment is transforming lives for children with Dravet syndrome, a severe form of epilepsy that can cause hundreds of seizures daily. Eight-year-old Freddie Truelove went from constant fits to just two seizures a week and is now skiing and climbing mountains.
An eight-month-old infant in Israel became the first person to receive groundbreaking gene therapy that restores missing brain function, potentially saving children from a devastating form of epilepsy. The treatment represents years of research turning into real hope for families facing ultra-rare genetic diseases.
A new biotech company just launched with $106 million to bring promising brain disorder treatments to Americans. Tortugas Neuroscience is testing four drugs for conditions that affect millions, including schizophrenia, tinnitus, and epilepsy.
Two boys with severe epilepsy are living seizure-reduced lives after receiving personalized gene therapy that targeted their unique brain abnormalities. The treatment also improved their developmental skills, offering new hope for families facing debilitating neurological disorders.
A groundbreaking drug called zorevunersen slashed seizures by up to 91% in children with Dravet syndrome, a devastating form of epilepsy that causes developmental delays and sudden death. Unlike other treatments, this drug tackles the genetic root cause and could change the course of the disease.
University of Virginia researchers used gene editing to fix the DNA mutation causing a deadly form of epilepsy, potentially opening the door to cures for inherited brain disorders. The technique eliminated seizures in lab mice and improved their movement and cognitive function.
Scientists discovered that brain inflammation drives Dravet syndrome, a devastating form of childhood epilepsy, opening the door to treatments that could help thousands of children. By blocking a specific immune pathway, researchers reduced seizures in early studies.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
A new HIV pill taken just once a week appears as effective as daily treatment in major studies. Over six million South Africans currently on daily HIV medication could benefit from simpler treatment.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Showing 20 of 7567